Form 4 Tracker
Faisal Ghiath Sukhtian

Director · 2 filings · Latest: Jul 29, 2026

Outlook Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
OTLK
Faisal Ghiath SukhtianDirectorJul 29, 2026
Purchase
$1.0595,398$100.0K220,972
OTLK
Faisal Ghiath SukhtianDirectorMay 27, 2026
Purchase
$0.4093122,174$50.0K125,574